-
公开(公告)号:US11992468B2
公开(公告)日:2024-05-28
申请号:US18184270
申请日:2023-03-15
发明人: Derek Moe , Randal Seburg , Sagar Rane
IPC分类号: A61K31/135 , A61K9/20 , G01N30/02
CPC分类号: A61K31/135 , A61K9/2009 , A61K9/2013 , A61K9/2018 , A61K9/2027 , A61K9/2054 , G01N2030/027
摘要: Disclosed herein are immediate release oral dosage forms that contain abuse-deterrent and abuse-resistant features. In particular, the disclosed dosage forms can provide deterrence of abuse by ingestion of multiple individual doses. The disclosed dosage forms can likewise provide protection from overdose in the event of accidental or intentional ingestion of multiple individual doses. The dosage forms may also exhibit abuse resistant properties when physically manipulated, and also when physically manipulated and then administered in a manner not consistent with oral dosing. The dosage forms may also exhibit abuse resistant properties when administered in a manner intended to result in administration of the esketamine in a higher than therapeutic dose.
-
公开(公告)号:US11957645B2
公开(公告)日:2024-04-16
申请号:US18193122
申请日:2023-03-30
发明人: Elena Kagan , Gina Pastino
IPC分类号: A61K31/135 , A61K9/00 , A61K9/16 , A61K31/136 , A61K31/15 , A61K31/343 , A61K31/36 , A61K31/381 , A61K31/7034 , A61P25/24
CPC分类号: A61K31/135 , A61K9/0053 , A61K9/1611 , A61K9/1623 , A61K9/1635 , A61K9/1652 , A61K9/167 , A61K31/136 , A61K31/15 , A61K31/343 , A61K31/36 , A61K31/381 , A61K31/7034 , A61P25/24
摘要: The present invention provides a method for safe and efficacious administration of esketamine.
-
公开(公告)号:US20230248666A1
公开(公告)日:2023-08-10
申请号:US18193083
申请日:2023-03-30
发明人: Johanna SCHUMANN , Dorit MIMROD
IPC分类号: A61K31/135 , A61P25/24 , A61K31/137 , A61K31/138 , A61K31/15 , A61K31/343 , A61K31/381 , A61K31/4525 , A61K45/06
CPC分类号: A61K31/135 , A61P25/24 , A61K31/137 , A61K31/138 , A61K31/15 , A61K31/343 , A61K31/381 , A61K31/4525 , A61K45/06
摘要: The present disclosure provides methods for safe and efficacious administration of esketamine.
-
公开(公告)号:US11648198B2
公开(公告)日:2023-05-16
申请号:US17015700
申请日:2020-09-09
发明人: Avshalom Ben Menachem , Ilan Zalit
CPC分类号: A61K9/0065 , A61K9/2013 , A61K9/2031 , A61K9/2054 , A61K9/2072 , A61M31/002
摘要: An oral gastro-retentive delivery device is provided which unfolds rapidly upon contact with gastric juice. The device is configured in a collapsed configuration for oral intake and unfolding for gastric retention for a predetermined period of time and eventually reducing in size for passage through the rest of the GI track.
-
公开(公告)号:US11577061B2
公开(公告)日:2023-02-14
申请号:US16903765
申请日:2020-06-17
摘要: The present disclosure is in the field of gastric resident systems. A device for extended retention in a stomach is provided. The device includes: first, second, and third arms, the second and third arms being pivotally connected to respective ends of the first arm. The device is configured to transform between a compressed configuration and an expanded configuration. The device further includes a biasing member configured to bias the device into the expanded configuration whereby the second and third arms are configured to mechanically engage each other to retain the system in the expanded configuration.
-
公开(公告)号:US20220211672A1
公开(公告)日:2022-07-07
申请号:US17607632
申请日:2020-05-01
发明人: Yael ROSEN , David DANGOOR , Richard FISHER
IPC分类号: A61K31/4174 , A61K31/4168 , A61K31/498 , A61K31/155 , A61K31/54 , A61P17/04 , A61K9/00 , A61K31/335 , A61K31/436 , A61K31/167 , A61K31/135 , A61K31/045 , A61K31/496 , A61K31/69 , A61K31/454 , A61K31/4164 , A61K31/195 , A61K31/485
摘要: The present disclosure related to methods of treating pruritus in a subject by topically administering an alpha-2 adrenoreceptor agonist to a subject.
-
公开(公告)号:US11207318B2
公开(公告)日:2021-12-28
申请号:US16751043
申请日:2020-01-23
IPC分类号: A61K31/485 , A61K9/16 , A61K31/167 , A61K31/165 , A61K31/515 , A61K31/5513 , A61K31/135 , A61K31/437 , A61K31/554 , A61K31/137 , A61K31/4458 , A61K9/20 , A61K31/192 , A61K31/4402 , A61K31/616 , A61K9/00 , A61K9/50 , A61K31/16
摘要: Described are immediate release oral dosage forms that contain abuse-deterrent features. In particular, the disclosed dosage forms provide deterrence of abuse by ingestion of multiple individual doses. In addition, the disclosed dosage forms provide protection from overdose in the event of accidental or intentional ingestion of multiple individual doses.
-
公开(公告)号:US20210378989A1
公开(公告)日:2021-12-09
申请号:US17284131
申请日:2019-10-11
发明人: Elena KAGAN
IPC分类号: A61K31/135 , A61K9/00 , A61K31/138 , A61K31/4525 , A61K31/343 , A61K31/137 , A61K31/381 , A61K31/15 , A61K31/5386 , A61K31/573 , A61K31/4025 , A61K31/198 , A61K31/485 , A61P25/24
摘要: The present invention provides a dosage regimen for safe and efficacious administration of esketamine and rapid-acting antidepressants in the treatment of major depressive disorder (MDD).
-
公开(公告)号:US11185495B2
公开(公告)日:2021-11-30
申请号:US16178147
申请日:2018-11-01
发明人: Erez Koren , Itzhak Shalev , Mark Zamansky
IPC分类号: A61K9/00 , A61K9/70 , A61K31/4174 , D06M16/00 , A61K31/196 , A61K31/192 , A61P23/02 , A61P17/06 , A61P37/08 , A61P25/00 , A61P29/00 , A61P31/10 , A61K31/167 , A61F13/00 , A61K47/10 , A61K47/26 , A61L15/44
摘要: The disclosure is directed to fibrous structures finished with active pharmaceutical ingredients, as well as methods of their manufacturer and use.
-
公开(公告)号:US20210323929A1
公开(公告)日:2021-10-21
申请号:US17148327
申请日:2019-07-18
发明人: Anton Frenkel , Vladimir Ioffe
IPC分类号: C07D233/58 , G01N33/15
摘要: The present disclosure relates to a purified detomidine HCl pharmaceutical product and to methods of preparation, validation of pharmaceutically acceptable product and use thereof.
-
-
-
-
-
-
-
-
-